A rapid and facile immunoassay for C-reactive protein using PDMS-based digital magnetofluidics
Pakakan Ngernpradab1, Kanet Wongravee2, Monpichar Srisa-Art1
1Electrochemistry and Optical Spectroscopy Center of Excellence, Department of Chemistry, Faculty of Science, Chulalongkorn University, Pathumwan, Bangkok, 10330, Thailand.
Analytica Chimica Acta
|August 18, 2024
Summary
This study introduces a rapid magnetofluidic immunoassay for C-reactive protein (CRP) detection. The novel method significantly reduces assay time, offering a faster alternative for inflammation and cardiovascular disease biomarker analysis.
Area of Science:
- Biomarker Discovery and Diagnostics
- Microfluidics and Lab-on-a-Chip Technologies
- Immunochemical Assays
Background:
- C-reactive protein (CRP) is a key biomarker for inflammation, tissue damage, and cardiovascular disease prediction.
- Traditional enzyme-linked immunosorbent assays (ELISAs) for CRP are time-consuming due to diffusion-limited mass transport.
- There is a need for rapid, facile, and efficient immunoassay methods for CRP analysis.
Purpose of the Study:
- To develop and validate a rapid magnetofluidic immunoassay for C-reactive protein (CRP) detection.
- To leverage a polydimethylsiloxane (PDMS) based magnetofluidic platform for enhanced immunoassay performance.
- To demonstrate the feasibility of a sandwich ELISA format on a microfluidic device for expedited CRP analysis.
Main Methods:
- A polydimethylsiloxane (PDMS) based magnetofluidic device was utilized for droplet manipulation.
- Superhydrophobic properties of PDMS enabled precise control of reagent and sample droplets via an external magnet.
- Magnetic beads functionalized with capture antibodies facilitated immunomagnetic separation (IMS) and droplet transport, accelerating assay steps.
Main Results:
- The magnetofluidic immunoassay successfully detected CRP within 1 hour.
- Achieved a limit of detection of 0.015 mg/L within a concentration range of 0.1-10 mg/L.
- Demonstrated high accuracy and precision with recovery rates of 90-114% and %RSD < 5% in human serum.
Conclusions:
- Magnetofluidic droplet control enables rapid and simplified execution of multi-step immunoassays.
- The microfluidic format conserves reagents and samples while enhancing assay kinetics.
- This approach presents a promising rapid, facile, and cost-effective alternative for various immunoassay applications.


